Tenderwize
Back to tender search

Open-house drug discount agreement for Fentanyl

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 29, 2028 · 466 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Fentanyl, nur Sublingualtabletten, Lutschtabletten oder Nasendosierspray, ATC N02AB03

56/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

56 / 100

Complexity

63 / 100

Risk factors

No value, volume forecast, minimum commitment, pricing detail, or demand information is provided.

The buyer may replace the open-house agreements with exclusive rebate contracts during the term, causing automatic term...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Feb 29, 2028

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Conclusion of non-exclusive pharmaceutical rebate agreements under Sections 130a(8) and 130c(1) SGB V.
  • Scope limited to Fentanyl, ATC N02AB03, in sublingual tablets, lozenges, or nasal-dose spray.
Show full summary

Open-house, non-exclusive pharmaceutical rebate agreement for Fentanyl (ATC N02AB03) in sublingual tablets, lozenges, or nasal-dose spray. Eligible pharmaceutical companies may join without a competitive selection decision under uniform, non-negotiable terms. The agreement period is 1 May 2026 to 30 April 2028, with monthly entry opportunities. Procurement documents are referenced but their substantive contents were not provided for analysis. No contract value is stated.

Risks

No value, volume forecast, minimum commitment, pricing detail, or demand information is provided.

The buyer may replace the open-house agreements with exclusive rebate contracts during the term, causing automatic term...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The participant must be a pharmaceutical company.
  • The offered medicines must be authorized and marketable in Germany.
  • Medicines listed as marketable in the Lauer-Taxe are treated as proven marketable.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Fentanyl Pharmaceutical Rebate Agreement

Non-exclusive open-house rebate agreement for authorized and marketable-in-Germany Fentanyl medicines in sublingual tablets, lozenges, or nasal-dose spray forms. Children’s medicines listed under the relevant BfArM list are excluded. Contracts may be concluded with all interested pharmaceutical companies under identical conditions.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Deadline

Deadline Feb 29, 2028

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
177930-2026

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy